Market Share of Alzheimer's Disease Diagnostics And Therapeutics Industry
The Alzheimer's disease diagnostics and therapeutics market is moderately competitive and consists of several significant players; some of the companies are F. Hoffmann-La Roche, Bristol-Myers Squibb, AstraZeneca PLC, Corium Inc., Eisai Co. Ltd, Biogen Inc., Johnson & Johnson, Eli Lilly and Company, Lupin Limited, AbbVie Inc., Siemens Healthineers, Zydus Cadila, Merz Pharma, Teva Pharmaceutical Industries Ltd, and Adamas Pharmaceuticals Inc.
Alzheimer's Disease Diagnostics And Therapeutics Market Leaders
F. Hoffmann-La Roche
Bristol-Myers Squibb
AstraZeneca PLC
Johnson & Johnson
Eli Lilly and Company
*Disclaimer: Major Players sorted in no particular order